Shingles vaccine - Zostavax

Zostavax® is given as part of a vaccine immunisation programme to protect against shingles.

It will be injected under your skin in your upper arm.

The most common side-effects are tenderness at the site of the injection and headache. These should soon pass.

Type of medicine Vaccine
Used for Prevention of shingles (herpes zoster) in people over 50 years of age
Also called Varicella-zoster vaccine
Available as Subcutaneous injection

Shingles is an infection of a nerve and the area of skin supplied by the nerve. It is caused by a virus called the varicella-zoster virus (this is the same virus that causes chickenpox). Shingles is sometimes called herpes zoster. The symptoms of shingles are a skin rash, blisters and pain. These occur in the area of skin that the infected nerve supplies. The pain may continue even after the skin blisters and rash have healed.

Shingles can occur at any age, but it is most common in people over the age of 50 years. A vaccine against the varicella-zoster virus has been shown to be effective in reducing the risk of older people developing shingles. In the UK from September 2013, a shingles vaccine immunisation programme will be introduced for people aged 70 years to protect against herpes zoster. Initially, there will also be a catch-up programme which will offer the vaccine to people 79 years of age.

Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before having Zostavax® make sure your doctor or pharmacist knows:

  • If you feel unwell or have a high temperature.
  • If you have been told you have a weakened immune system. This may be a result of an illness or taking other medicines.
  • If you have ever had an allergic reaction to a medicine.
  • If you are taking any other medicines. This includes any medicines you are taking which are available to buy without a prescription, such as herbal and complementary medicines.
  • If you could be pregnant.
  • Before you are given this treatment, ask to read the manufacturer's printed information leaflet from inside the pack. The leaflet will give you more information about the vaccine and a full list of side-effects which you may experience from having it.
  • You will be given one dose of the vaccine by your doctor or nurse. It will be injected just underneath your skin, usually in your upper arm.

Along with their useful effects, all medicines can cause unwanted side-effects although not everyone experiences them. Speak with your doctor or pharmacist if any of the following side-effects continue or become troublesome.

Common Zostavax® side-effects What can I do if I experience this?
Pain, redness, swelling, or itching at the site of the injection This should soon pass
Headache If troublesome, take a dose of a suitable painkiller

If you experience any other symptoms which you think may be due to this vaccine, speak with your doctor or pharmacist.

  • It is unlikely that you will be asked to store the vaccine before it is given to you. If, however, this does happen, keep it refrigerated until it is needed.
  • Keep all medicines out of the reach and sight of children.
  • Store in a cool, dry place, away from direct heat and light.

If you are having an operation or any dental treatment, tell the person carrying out the treatment which medicines you are taking.

If you have any questions about this medicine ask your pharmacist.

Further reading & references

  • Manufacturer's PIL, Zostavax®; Sanofi Pasteur MSD Limited, The electronic Medicines Compendium. Dated February 2013.
  • British National Formulary; 65th Edition (Mar 2013) British Medical Association and Royal Pharmaceutical Society of Great Britain, London

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Helen Allen
Current Version:
Peer Reviewer:
Prof Cathy Jackson
Last Checked:
11/05/2013
Document ID:
28611 (v1)
© EMIS
The Information Standard - certified member